-
1
-
-
0026092912
-
Genetic analysis of breast cancer in the cancer and steroid hormone study
-
Claus EB, Risch N, Thompson D. 1991. Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet 48:232-42.
-
(1991)
Am J Hum Genet
, vol.48
, pp. 232-242
-
-
Claus, E.B.1
Risch, N.2
Thompson, D.3
-
3
-
-
0027433563
-
Genetic linkage analysis in familial breast and ovarian cancer
-
Easton DF, Bishop DT, Ford D, Crockford GP, the Breast Cancer Linkage Consortium. 1993. Genetic linkage analysis in familial breast and ovarian cancer. Am J Hum Genet 52:678-701.
-
(1993)
Am J Hum Genet
, vol.52
, pp. 678-701
-
-
Easton, D.F.1
Bishop, D.T.2
Ford, D.3
Crockford, G.P.4
-
4
-
-
0028843102
-
Breast and ovarian cancer incidence in BRCA1-mutation carriers
-
Easton DF, Ford D, Bishop DT, and the Breast Cancer Linkage Consortium. 1995. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56:265-71.
-
(1995)
Am J Hum Genet
, vol.56
, pp. 265-271
-
-
Easton, D.F.1
Ford, D.2
Bishop, D.T.3
-
5
-
-
16944365740
-
Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13
-
Easton DF, Steele L, Fields P, Ormiston W, Averill D, Daly PA, McManus R, Neuhausen SL, Ford D, Wooster R, Cannon-Albright LA, Stratton MR, Goldgar DE. 1997. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet 61:120-8.
-
(1997)
Am J Hum Genet
, vol.61
, pp. 120-128
-
-
Easton, D.F.1
Steele, L.2
Fields, P.3
Ormiston, W.4
Averill, D.5
Daly, P.A.6
McManus, R.7
Neuhausen, S.L.8
Ford, D.9
Wooster, R.10
Cannon-Albright, L.A.11
Stratton, M.R.12
Goldgar, D.E.13
-
6
-
-
0028330276
-
Risks of cancer in BRCAl-mutation carriers
-
Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE, and the Breast Cancer Linkage Consortium. 1994. Risks of cancer in BRCAl-mutation carriers. Lancet 343:692-5.
-
(1994)
Lancet
, vol.343
, pp. 692-695
-
-
Ford, D.1
Easton, D.F.2
Bishop, D.T.3
Narod, S.A.4
Goldgar, D.E.5
-
7
-
-
0028826709
-
Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence
-
Ford D, Easton D, Peto J. 1995. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57:1457-62.
-
(1995)
Am J Hum Genet
, vol.57
, pp. 1457-1462
-
-
Ford, D.1
Easton, D.2
Peto, J.3
-
8
-
-
17344365851
-
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
-
Ford D, Easton DF, Stratton M, Narod S. Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BAJ, Gayther SA, Birch JM, Lindblom A, Stoppa-Lyonnet D, Bignon Y, Borg A, Hamann U, Haites N, Scott RJ, Maugard CM, Vasen H, Seitz S, Cannon-Albright LA, Schofield A, Zelada, Hedman M, and the Breast Cancer Linkage Consortium. 1998. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62:676-89.
-
(1998)
Am J Hum Genet
, vol.62
, pp. 676-689
-
-
Ford, D.1
Easton, D.F.2
Stratton, M.3
Narod S Goldgar, D.4
Devilee, P.5
Bishop, D.T.6
Weber, B.7
Lenoir, G.8
Chang-Claude, J.9
Sobol, H.10
Teare, M.D.11
Struewing, J.12
Arason, A.13
Scherneck, S.14
Peto, J.15
Rebeck, T.R.16
Tonin, P.17
Neuhausen, S.18
Barkardottir, R.19
Eyfjord, J.20
Lynch, H.21
Ponder, B.A.J.22
Gayther, S.A.23
Birch, J.M.24
Lindblom, A.25
Stoppa-Lyonnet, D.26
Bignon, Y.27
Borg, A.28
Hamann, U.29
Haites, N.30
Scott, R.J.31
Maugard, C.M.32
Vasen, H.33
Seitz, S.34
Cannon-Albright, L.A.35
Schofield, A.36
Zelada, H.M.37
more..
-
9
-
-
0028844202
-
Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation
-
Gayther SA, Warren W, Mazoyer S, Russel P, Harrington P, Chiano M, Seal S, Hamoudi R, van Rensburg EJ, Dunning AM, Love R, Evans G, Easton DF, Clayton D, Stratton M, Ponder BAJ. 1995. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet 11:428-33.
-
(1995)
Nat Genet
, vol.11
, pp. 428-433
-
-
Gayther, S.A.1
Warren, W.2
Mazoyer, S.3
Russel, P.4
Harrington, P.5
Chiano, M.6
Seal, S.7
Hamoudi, R.8
Van Rensburg, E.J.9
Dunning, A.M.10
Love, R.11
Evans, G.12
Easton, D.F.13
Clayton, D.14
Stratton, M.15
Ponder, B.A.J.16
-
10
-
-
0031012305
-
Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene
-
Gayther SA, Mangion J, Russel P, Seal S, Barfoot R, Ponder BAJ, Stratton MR, Easton DF. 1997. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet 15:103-5.
-
(1997)
Nat Genet
, vol.15
, pp. 103-105
-
-
Gayther, S.A.1
Mangion, J.2
Russel, P.3
Seal, S.4
Barfoot, R.5
Ponder, B.A.J.6
Stratton, M.R.7
Easton, D.F.8
-
11
-
-
0343924909
-
The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer and the implications for predictive testing
-
in press
-
Gayther SA, Russel P, Harrington P, Antoniou AC, Easton DF, Ponder BAJ. The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer and the implications for predictive testing. Am J Hum Genet (in press).
-
Am J Hum Genet
-
-
Gayther, S.A.1
Russel, P.2
Harrington, P.3
Antoniou, A.C.4
Easton, D.F.5
Ponder, B.A.J.6
-
12
-
-
16944367027
-
Moderate frequency of BRCA1 and BRCA2 germ-line mutations in scandinavian familial breast cancer
-
Hakansson S, Johanson O, Johanson U, Sellberg G, Loman N, Gereds AM, Holmberg E, Dahl N, Pandis N, Kristofferson U, Olson H, Borg A. 1997. Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Am J Hum Genet 60:1068-78.
-
(1997)
Am J Hum Genet
, vol.60
, pp. 1068-1078
-
-
Hakansson, S.1
Johanson, O.2
Johanson, U.3
Sellberg, G.4
Loman, N.5
Gereds, A.M.6
Holmberg, E.7
Dahl, N.8
Pandis, N.9
Kristofferson, U.10
Olson, H.11
Borg, A.12
-
13
-
-
0025613812
-
Linkage of early onset familial breast cancer to chromosome 17q21
-
Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC. 1990. Linkage of early onset familial breast cancer to chromosome 17q21. Science 250:1684-9.
-
(1990)
Science
, vol.250
, pp. 1684-1689
-
-
Hall, J.M.1
Lee, M.K.2
Newman, B.3
Morrow, J.E.4
Anderson, L.A.5
Huey, B.6
King, M.C.7
-
14
-
-
0030754173
-
Comparison of self-reported and database-linked family history of cancer data in a case-control study
-
Kerber RA, Slattery ML. 1997. Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol 146:244-8.
-
(1997)
Am J Epidemiol
, vol.146
, pp. 244-248
-
-
Kerber, R.A.1
Slattery, M.L.2
-
15
-
-
0024190141
-
Programs for pedigree analysis: MENDEL, FISHER, and dGENE
-
Lange K, Weeks D. 1988. Programs for pedigree analysis: MENDEL, FISHER, and dGENE. Genet Epidemiol 5:471-2.
-
(1988)
Genet Epidemiol
, vol.5
, pp. 471-472
-
-
Lange, K.1
Weeks, D.2
-
16
-
-
0028885339
-
An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families
-
Narod S, Ford D, Devilee P, Barkardottir RB, Lynch HT, Smith SA, Ponder BA, Weber BL, Garber JE, Birch JM, Cornellis RS, Kelsell DP, Spurr NK, Smyth E, Haites N, Sobol H, Bingon YJ, Chang-Claude J, Hamann U, Lindblom A, Borg A, Pirer MS, Gallion HH, Struewing JP, Whittemore A, Tonin P, Goldgar DE, Easton DE and the Breast Cancer Linkage Consortium. 1995. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Am J Hum Genet 56:254-64.
-
(1995)
Am J Hum Genet
, vol.56
, pp. 254-264
-
-
Narod, S.1
Ford, D.2
Devilee, P.3
Barkardottir, R.B.4
Lynch, H.T.5
Smith, S.A.6
Ponder, B.A.7
Weber, B.L.8
Garber, J.E.9
Birch, J.M.10
Cornellis, R.S.11
Kelsell, D.P.12
Spurr, N.K.13
Smyth, E.14
Haites, N.15
Sobol, H.16
Bingon, Y.J.17
Chang-Claude, J.18
Hamann, U.19
Lindblom, A.20
Borg, A.21
Pirer, M.S.22
Gallion, H.H.23
Struewing, J.P.24
Whittemore, A.25
Tonin, P.26
Goldgar, D.E.27
Easton, D.E.28
more..
-
17
-
-
0032514413
-
Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary ovarian cancer clinical study group
-
Narod SA, Risch H, Moslehi R, Dorum A, Neuhausen S, Olsson H, Provencher D, Radice P, Evans G, Bishop S, Brunet JS, Ponder BAJ. 1998. Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group. N Engl J Med 339:424-8.
-
(1998)
N Engl J Med
, vol.339
, pp. 424-428
-
-
Narod, S.A.1
Risch, H.2
Moslehi, R.3
Dorum, A.4
Neuhausen, S.5
Olsson, H.6
Provencher, D.7
Radice, P.8
Evans, G.9
Bishop, S.10
Brunet, J.S.11
Ponder, B.A.J.12
-
18
-
-
13344268996
-
Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus
-
Phelan CM, Rebbeck R, Weber B, Devilee P, Ruttledge MH, Lynch HT, Lenoir GM, Stratton MR, Easton DF, Ponder BAJ, Cannon-Albright L, Larsson C. 1996. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nat Genet 12:309-11.
-
(1996)
Nat Genet
, vol.12
, pp. 309-311
-
-
Phelan, C.M.1
Rebbeck, R.2
Weber, B.3
Devilee, P.4
Ruttledge, M.H.5
Lynch, H.T.6
Lenoir, G.M.7
Stratton, M.R.8
Easton, D.F.9
Ponder, B.A.J.10
Cannon-Albright, L.11
Larsson, C.12
-
19
-
-
0031003498
-
Contribution of BRCA1 mutations to ovarian cancer
-
Stratton JF, Gayther SA, Russell P, Dearden J, Gore M, Blake P, Easton DF, Ponder BAJ. 1997. Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med 336:1125-30.
-
(1997)
N Engl J Med
, vol.336
, pp. 1125-1130
-
-
Stratton, J.F.1
Gayther, S.A.2
Russell, P.3
Dearden, J.4
Gore, M.5
Blake, P.6
Easton, D.F.7
Ponder, B.A.J.8
-
20
-
-
0031812042
-
A systematic review and meta-analysis of family history and risk of ovarian cancer
-
Stratton JF, Pharoah P, Smith KS, Easton DF, Ponder BAJ. 1998. A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol 105:493-9.
-
(1998)
Br J Obstet Gynaecol
, vol.105
, pp. 493-499
-
-
Stratton, J.F.1
Pharoah, P.2
Smith, K.S.3
Easton, D.F.4
Ponder, B.A.J.5
-
21
-
-
0030910022
-
The risk associated with specific mutations of BRCA1 and BRCA2 among ashkenazi jews
-
Struewing JP, Hartge P, Wacholder S, Baker S, Berlin M, McAdams M, Timmerman M, Brody LC, Tucker MA. 1997. The risk associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401-8.
-
(1997)
N Engl J Med
, vol.336
, pp. 1401-1408
-
-
Struewing, J.P.1
Hartge, P.2
Wacholder, S.3
Baker, S.4
Berlin, M.5
McAdams, M.6
Timmerman, M.7
Brody, L.C.8
Tucker, Ma.9
-
22
-
-
0031025322
-
Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: Results from three U.S. Population-based case-control studies of ovarian cancer
-
Whittemore A, Gong G, Intyre J. 1997. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer. Am J Hum Genet 60:496-504.
-
(1997)
Am J Hum Genet
, vol.60
, pp. 496-504
-
-
Whittemore, A.1
Gong, G.2
Intyre, J.3
-
23
-
-
0028006563
-
Localisation of a breast cancer susceptibility gene (BRCA2) to chromosome 13q by genetic linkage analysis
-
Wooster R, Neuhausen S, Mangion J, Quirke Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, Patty F, Marshall G, Narod S, Lenoir G, Lynch H, Feunteun J, Devilee P, Cornelisse CJ, Menko F, Daly PA, Ormiston W, McManus R, Pye C, Lewis C, Cannon-Albright LA, Peto J, Ponder BAJ, Skolick MH, Easton DFE, Goldgar DE, Stratton MR. 1994. Localisation of a breast cancer susceptibility gene (BRCA2) to chromosome 13q by genetic linkage analysis. Science 265:2088-90.
-
(1994)
Science
, vol.265
, pp. 2088-2090
-
-
Wooster, R.1
Neuhausen, S.2
Mangion, J.3
Quirke, Y.4
Ford, D.5
Collins, N.6
Nguyen, K.7
Seal, S.8
Tran, T.9
Averill, D.10
Patty, F.11
Marshall, G.12
Narod, S.13
Lenoir, G.14
Lynch, H.15
Feunteun, J.16
Devilee, P.17
Cornelisse, C.J.18
Menko, F.19
Daly, P.A.20
Ormiston, W.21
McManus, R.22
Pye, C.23
Lewis, C.24
Cannon-Albright, L.A.25
Peto, J.26
Ponder, B.A.J.27
Skolick, M.H.28
Easton, D.F.E.29
Goldgar, D.E.30
Stratton, M.R.31
more..
|